Home » Topics » BioWorld Science

BioWorld Science
RSS

Takeda reports oral cephem antibacterials

May 17, 1996

ALA PDT results outstanding in patients with precancerous actinic keratoses

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Allergan claims retinoid-like compounds for dermatologic indications

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...